Hair loss becomes more difficult to manage as thinning progresses, especially when the scalp begins to show through large areas. ACell PRP Therapy in Dubai is promoted as a regenerative approach that combines platelet-rich plasma with an extracellular matrix product to support weakened hair follicles. But can it genuinely help when hair loss is already advanced? The answer is more nuanced than a simple yes or no. PRP has growing clinical evidence for androgenetic alopecia, while evidence specifically supporting the addition of ACell remains limited.
ACell PRP therapy combines two different concepts. PRP is prepared from a patient's own blood and contains concentrated platelets and signaling proteins involved in tissue repair. ACell, historically associated with MatriStem products, is an extracellular matrix material derived from animal tissue and has been used in regenerative and wound-healing applications.
The rationale behind combining them is that PRP may provide growth-related signals while the extracellular matrix is intended to provide a supportive biological scaffold. In theory, this combination could create a favorable environment around weakened follicles.
However, it is important to distinguish biological theory from proven clinical effectiveness. A small published case report described two patients receiving PRP with MatriStem for pattern hair loss, but the authors emphasized that controlled studies were needed to determine whether the approach produces consistent results.
The strongest evidence behind ACell PRP therapy comes from the PRP component rather than ACell itself.
Several systematic reviews and meta-analyses have found that PRP can increase hair density in people with androgenetic alopecia. For example, a 2024 meta-analysis of randomized controlled trials found a significant increase in hair density following PRP treatment, although the evidence was affected by differences between studies and relatively small sample sizes.
Another 2024 systematic review of randomized trials found that PRP increased hair density, with some evidence of benefit at three and six months. Nevertheless, researchers noted that study protocols varied considerably, making it difficult to establish one universally effective PRP protocol.
More recent evidence also suggests that PRP should not automatically be considered superior to established treatments. A 2026 systematic review and meta-analysis comparing PRP with topical minoxidil found no clear advantage for PRP in important measures such as hair density, terminal hair count, or moderate-to-high regrowth.
This means PRP appears promising, but expectations should remain realistic.
Advanced hair loss presents a bigger challenge because the number and condition of functioning follicles become increasingly important.
PRP is generally more useful when follicles are still present but weakened or miniaturized. If an area has been completely bald for a long period, there may be fewer viable follicles capable of responding to regenerative stimulation.
Therefore, ACell PRP for advanced hair loss should not be viewed as a guaranteed way to recreate large amounts of lost hair. Its potential is more relevant to areas where thinning follicles remain.
The distinction is important: